Home›Macitentan And Tadalafil›Macitentan And Tadalafil + Itraconazole

Does Macitentan And Tadalafil Interact with Itraconazole?

CDI records a contraindicated classification for Macitentan And Tadalafil and Itraconazole. The stored summary is: Strong CYP3A4 inhibitor that increases exposure to both macitentan and tadalafil. Avoid concomitant use. The mechanism involves cyp3a4 inhibition. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.

Severity
Contraindicated
Macitentan And Tadalafil Class
Endothelin Receptor Antagonist
Itraconazole Class
Azole Antifungal
Management
Do not take together
Data Source
U.S. FDA via OpenFDA

Recorded Mechanism

CYP3A4 inhibition

What To Tell Your Doctor or Pharmacist

If you are taking Macitentan And Tadalafil and your doctor is considering prescribing Itraconazole (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask about alternative medications that do not interact with your current regimen
  • Ask how frequently you should be monitored while these are co-prescribed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Macitentan And Tadalafil(Opsynvi)+💊 Itraconazole(Sporanox)

Severity & Interaction Details

⛔
contraindicated
Avoid this combination
CDI classifies this record as contraindicated. Confirm the applicable product labeling with your prescriber or pharmacist.
Severity scale
MinorContra
On record
Yes
Drug A class
Endothelin Receptor Antagonist
Drug B class
Azole Antifungal
Source
NLP:macitentan and tadalafil

What this means in plain English

Strong CYP3A4 inhibitor that increases exposure to both macitentan and tadalafil. Avoid concomitant use.

About Macitentan And Tadalafil and Itraconazole

Macitentan And Tadalafil is an Endothelin Receptor Antagonist, while Itraconazole is an Azole Antifungal. You may recognize them by the brand names Opsynvi and Sporanox. Both Macitentan And Tadalafil and Itraconazole carry an FDA boxed warning — the agency's most serious safety designation.

Source and Limitations

This record was produced by automated extraction from drug-label information, including AI processing. The summary and mechanism are not verbatim FDA quotations. The drug profiles below may describe different formulations from the source label. Confirm the exact product and route with your pharmacist. This page does not establish independent clinical review.

📖 Source: NLP:macitentan and tadalafil

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Macitentan And Tadalafil and Itraconazole against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
How this information is prepared: CDI uses automated extraction, including AI, to summarize drug labeling from openFDA and includes separately identified curated-reference records. RxNorm helps identify medications; it does not verify interaction claims. Extracted summaries and CDI severity classifications can contain errors and are not verbatim FDA statements or independent clinical review. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.

CDI: source-linked explanations